Arbekacin
Arbekacin, an aminoglycoside antibiotic, exhibits broad antimicrobial activities against not only Gram-positive bacteria but also Gram-negative bacteria.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 51025-85-5
- Formel: C22H44N6O10
- Molecular Weight:552.62
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Antibiotic Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Arbekacin potently inhibits Acinetobacter baumannii. (MIC50=2 μg/mL) and Enterobacteriaceae from PHP (MIC50=0.25-2 μg/mL; MIC90=1-8 μg/mL)[1].
Arbekacin also inhibits worldwide well-characterized MDR Gram-negative and MRSA strains[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 51025-85-5
-
Molecular Weight 552.62
-
Formel C22H44N6O10
-
SMILES
O[C@H]1[C@H](O[C@@H]2[C@@H](CC[C@@H](O2)CN)N)[C@@H](N)C[C@@H](NC([C@@H](O)CCN)=O)[C@@H]1O[C@H]3O[C@H](CO)[C@H](O)[C@H](N)[C@H]3O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Matsumoto T. Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens. Clin Pharmacol. 2014 Sep 26;6:139-48. [Content Brief]
[2]. Sader HS, et al. Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia. Antimicrob Agents Chemother. 2015;59(6):3263-70. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)